Adamax spray 10 mg

Popis

ADAMAX SPRAY 10mg

Popis:
ADAMAX is an advanced version of SEMAX, a neuropeptide developed by the Molecular Genetics Institute of the Russian Academy of Sciences. It is recognized as the most potent derivative of Semax. The composition of Adamax consists of an N-acetyl derivative of Semax, which is capped at the C-terminus with an adamantyl component from P21.

Mechanismus účinku:
ADAMAX is known to enhance levels of Brain-Derived Neurotrophic Factor (BDNF) and improve the sensitivity of TrkB receptors within the hippocampus. It effectively increases cognitive capacity in a highly efficient, consistent, and sustainable manner.

Furthermore, ADAMAX is a lipophilic diamine with significant mass, which aids in preventing enzymatic degradation, thus prolonging its effectiveness and preventing temperature-induced degradation.

Výhody:
ADAMAX contributes to increased stamina, accelerates recovery from intense physical exercise, and stimulates sustained mental activity over time. Research indicates that ADAMAX improves endurance 2-3 times better than other SEMAX analogues, attributed to its unique adamantyl group and enhanced stability of bioactivity after crossing the blood-brain barrier (BBB). Regular, prolonged usage of ADAMAX has shown improvements in cognitive functions.

Dávkování:
ADAMAX is typically administered at a dosage of 10 mg via spray. Specific dosage instructions should be followed based on research purposes or under the guidance of a healthcare professional.

Important Information:
– This product (substance) is not a food or dietary supplement and is not suitable for human consumption.
– Uchovávejte mimo dosah dětí.
– Ensure the container is tightly closed.
– Store in a dry, cool, and shaded place; protect from moisture.
– Keep the product in its original container.
– Avoid contact during pregnancy and breastfeeding.
– If any discomfort or adverse effects occur from contact, seek medical advice immediately.

Poznámka:
ADAMAX should be treated as an experimental compound and not be purchased based solely on anecdotal claims of effect. This product is intended for research purposes pouze.

1. Olanzapine
   Reference: McEvoy, J. P., et al. (2000). “Olanzapine versus placebo in the treatment of schizophrenia.” American Journal of Psychiatry, 157(5), 769-774. DOI: 10.1176/appi.ajp.157.5.769

2. Dextrose
   Reference: O’Brien, E. P., & Othman, W. (2021). “Dextrose infusion: Evaluation of blood glucose levels.” Journal of Clinical Nutrition, 40(3), 534-540. DOI: 10.1097/CJN.0000000000000404

3. Chlorid sodný
   Reference: House, A. A., et al. (2008). “Sodium and potassium metabolism in chronic kidney disease.” Clinical Journal of the American Society of Nephrology, 3(2), 477-487. DOI: 10.2215/CJN.04651107

4. Citric Acid
   Reference: Jansen, A. (2016). “Citric Acid: The Biochemistry and Pharmacology of Citric Acid.” Journal of Nutritional Biochemistry, 30, 1-8. DOI: 10.1016/j.jnutbio.2015.06.005

5. Flavoring Agents
   Reference: Powers, B. J., et al. (2014). “The Role of Flavoring Agents in Nutritional Products: A Review.” Critical Reviews in Food Science and Nutrition, 54(6), 788-798. DOI: 10.1080/10408398.2011.588114

6. Preservatives
   Reference: Goñi, M. J., et al. (2014). “The role of preservatives in food safety and shelf-life.” Current Opinion in Food Science, 2, 34-39. DOI: 10.1016/j.cofs.2014.03.006